-
Anti-vimentin nanobody decreases glioblastoma cell invasion in vitro and in vivo [Elektronski vir]Zottel, Alja ...Purpose: Glioblastoma (GBM) is the most common primary brain tumour and one of the deadliest cancers. In addition to late diagnosis and inadequate treatment, the extremely low survival rate is also ... due to the lack of appropriate therapeutic biomarkers and corresponding therapeutic agents. One of the potential therapeutic biomarkers is the intermediate filament vimentin, which is associated with epithelial-mesenchymal transition (EMT). The purpose of this study was to analyse the effect of the anti-vimentin nanobody Nb79 on cell invasion in vitro and in vivo. To further our understanding of the mechanism of action, we investigated the association between Nb79 and EMT in GBM and GBM stem cells by analysing the expression levels of key EMT-related proteins. Methods: The expression of vimentin in glioma tissues and cells was determined by RT-qPCR. An invasion assay was performed on differentiated glioblastoma cell line U-87 MG and stem cell line NCH421k in vitro as well as in vivo in zebrafish embryos. The effect of Nb79 on expression of EMT biomarkers beta-catenin, vimentin, ZEB-1 and ZO1 was determined by Western blot and immunocytochemistry. Results: Our study shows that vimentin is upregulated in glioblastoma tissue compared to lower grade glioma and non-tumour brain tissue. We demonstrated that treatment with Nb79 reduced glioblastoma cell invasion by up to 64% in vitro and up to 21% in vivo. In addition, we found that the tight junction protein ZO-1 had higher expression on the cell membrane, when treated with inhibitory anti-vimentin Nb79 compared to control. Conclusion: In conclusion, our results suggest that anti-vimentin nanobody Nb79 is a promising tool to target glioblastoma cell invasion.Vir: Cancers [Elektronski vir]. - ISSN 2072-6694 (Vol. 15, no. 3, 2023, str. 1-14)Vrsta gradiva - e-članekLeto - 2023Jezik - angleškiCOBISS.SI-ID - 138228995
Avtor
Zottel, Alja |
Novak, Metka, biokemija, 1985- |
Šamec, Neja, 1983- |
Majc, Bernarda |
Colja, Sara, farmacevtka |
Katrašnik, Mojca, mikrobiologinja |
Vittori, Miloš |
Hrastar, Barbara |
Rotter, Ana |
Porčnik, Andrej, 1984- |
Lah Turnšek, Tamara |
Komel, Radovan |
Breznik, Barbara, 1989- |
Jovchevska, Ivana
Teme
glioblastom |
vimentin |
nanotelo |
glioblastoma |
vimentin |
nanobody
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Avtor | Zottel, Alja ... |
Naslov | Anti-vimentin nanobody decreases glioblastoma cell invasion in vitro and in vivo [Elektronski vir] |
Datum objave | 2023-01-17 |
COBISS.SI-ID | 138228995 |
Verzija objave v repozitoriju | Založnikova različica |
Licenca objave v repozitoriju | Creative Commons Priznanje avtorstva 4.0 Mednarodna |
Embargo | Takojšnja javna objava |
Projekti, iz katerih je bila financirana objava
Naziv | Akronim | Številka projekta | Financer |
---|---|---|---|
Vpliv imunoterapije z anti-PD-L1 atezolizumabom in nanotelesom Nb202 na organoide glioblastoma pripravljene iz tkiva bolnikov | Z3-4510-2022 |
Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije |
|
Funkcijska genomika in biotehnologija za zdravje | P1-0390-2022 |
Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije |
|
Ekotoksiologija, toksikološka genomika in karcinogeneza | P1-0245-2019 |
Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije |
|
Morska in mikrobna biotehnologija | P4-0432-2022 |
Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije |
|
Z vizualizacijo mikrookolja glioblastoma do boljše terapije | J3-4504-2022 |
Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije |
|
Določitev novih biomarkerjev glioblastoma za namen neinvazivne tekočinske biopsije | Z3-2649-2020 |
Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije |
|
TWINNING FOR EXCELLENCE TO STRATEGICALLY ADVANCE RESEARCH IN CARCINOGENESIS AND CANCER | CutCancer | 101079113 |
European Commission |
Datoteke, ki spadajo k objavi
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Zottel, Alja | 39126 |
Novak, Metka, biokemija, 1985- | 32116 |
Šamec, Neja, 1983- | 33735 |
Majc, Bernarda | 51984 |
Colja, Sara, farmacevtka | 58674 |
Katrašnik, Mojca, mikrobiologinja | ![]() |
Vittori, Miloš | 32060 |
Hrastar, Barbara | ![]() |
Rotter, Ana | 27503 |
Porčnik, Andrej, 1984- | 36804 |
Lah Turnšek, Tamara | 07802 |
Komel, Radovan | 06135 |
Breznik, Barbara, 1989- | 36319 |
Jovchevska, Ivana | 38279 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.